UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034048
Receipt number R000038811
Scientific Title Evaluation of usefulness of GIF-2TQ260M in endoscopic submucosal dissection for gastric cancer.
Date of disclosure of the study information 2018/09/05
Last modified on 2021/09/07 13:05:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of usefulness of GIF-2TQ260M in endoscopic submucosal dissection for gastric cancer.

Acronym

Evaluation of GIF-2TQ260M in ESD for gastric cancer.

Scientific Title

Evaluation of usefulness of GIF-2TQ260M in endoscopic submucosal dissection for gastric cancer.

Scientific Title:Acronym

Evaluation of GIF-2TQ260M in ESD for gastric cancer.

Region

Japan


Condition

Condition

gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of endoscopic submucosal dissection using the GIF-2TQ260M for gastric cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

procedure time

Key secondary outcomes

accident occurrence rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

GIF-2TQ260M

Interventions/Control_2

other scopes

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

95 years-old >

Gender

Male and Female

Key inclusion criteria

1. Diagnosed with gastric cancer.
2. The absolute indication and expanded indications in the Gastric Cancer Treatment Guidelines.
3. one leision
4. Tumor location upper or middle
5. PS 0 or 1 or2




Key exclusion criteria

a pregnant woman
residual stomach cancer

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Koichi
Middle name
Last name Hamada

Organization

Southern Tohoku general hospital

Division name

Gastroenterology

Zip code

963-8563

Address

7-115, Yatsuyamada, Koriyama-shi

TEL

0249345322

Email

koichi.hamada@mt.strins.or.jp


Public contact

Name of contact person

1st name Koichi
Middle name
Last name Hamada

Organization

Southern Tohoku general hospital

Division name

Gastroenterology

Zip code

963-8563

Address

7-115, Yatsuyamada, Koriyama-shi

TEL

0249345322

Homepage URL


Email

koichi.hamada@mt.strins.or.jp


Sponsor or person

Institute

Southern Tohoku general hospital

Institute

Department

Personal name



Funding Source

Organization

non

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Southern Tohoku General Hospital

Address

7-115, Yatsuyamada, Koriyama-shi, Fukushima 963-8563, Japan

Tel

0249345322

Email

koichi.hamada@mt.strins.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 05 Day


Related information

URL releasing protocol

https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1288-0570

Publication of results

Published


Result

URL related to results and publications

https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1288-0570

Number of participants that the trial has enrolled

60

Results

Sixty patients were analyzed; 30 who underwent C-ESD and 30 who underwent M-ESD. The mean ESD procedure times for the M-ESD and C-ESD groups were 34.6+-17.2 and 47.2+-26.7 minutes, respectively (p=0.034). Muscle layer damage occurred significantly less frequently in the M-ESD group (0.2+-0.7 vs 0.7+-1.0; p=0.036).

Results date posted

2021 Year 09 Month 07 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Participants who were scheduled to receive gastric ESD were enrolled in this study. The inclusion criteria were as follows: participants >= 20 years of age; participants with histologically proven gastric adenocarcinoma; and participants who met the absolute or expanded indication for ESD according to the Japanese gastric cancer treatment guidelines 2014 (ver. 4);

Participant flow

A total of 60 patients were enrolled and analyzed. Thirty patients were assigned to the C-ESD and M-ESD groups, respectively.

Adverse events

No significant differences were noted in the incidence of delayed bleeding, intraoperative perforation, and delayed perforation between the C-ESD and the M-ESD groups. Damage to the muscle layers occurred significantly less frequently in the M-ESD group

Outcome measures

The primary outcome was the ESD procedure time. The secondary outcomes were the dissection speed and operative complications; intraoperative perforation, delayed bleeding, delayed perforation, and damage to the muscle layers during ESD.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 07 Month 01 Day

Date of IRB

2018 Year 07 Month 08 Day

Anticipated trial start date

2018 Year 09 Month 06 Day

Last follow-up date

2019 Year 12 Month 29 Day

Date of closure to data entry

2020 Year 06 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 05 Day

Last modified on

2021 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038811


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2021/09/07 umin upload.xlsx